| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
60,870 |
59,000 |
$3.77M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
35,583 |
33,784 |
$3.21M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
60,340 |
29,145 |
$1.15M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
10,154 |
10,135 |
$893K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
8,894 |
8,882 |
$746K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,771 |
5,567 |
$475K |
| 90461 |
|
13,943 |
12,137 |
$412K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,314 |
3,310 |
$312K |
| 92552 |
|
4,957 |
4,951 |
$109K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,318 |
2,305 |
$96K |
| 99173 |
|
19,111 |
19,085 |
$88K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,153 |
2,139 |
$71K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
572 |
569 |
$48K |
| 96127 |
|
11,591 |
9,537 |
$47K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
2,555 |
2,407 |
$38K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
839 |
826 |
$30K |
| 36416 |
|
9,040 |
8,996 |
$23K |
| 99177 |
|
12,453 |
12,434 |
$20K |
| 99188 |
|
1,595 |
1,594 |
$19K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,063 |
1,053 |
$14K |
| 99215 |
Prolong outpt/office vis |
91 |
88 |
$11K |
| 94760 |
|
4,179 |
4,073 |
$7K |
| 0071A |
|
121 |
121 |
$4K |
| 83655 |
|
293 |
293 |
$4K |
| 0072A |
|
93 |
93 |
$3K |
| 87081 |
|
385 |
379 |
$2K |
| 0001A |
|
57 |
56 |
$2K |
| 85018 |
|
836 |
833 |
$2K |
| 0002A |
|
49 |
49 |
$2K |
| 82465 |
|
355 |
353 |
$2K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
191 |
190 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
203 |
203 |
$1K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
12 |
12 |
$720.00 |
| 90686 |
|
7,066 |
7,047 |
$453.77 |
| 90480 |
|
12 |
12 |
$440.00 |
| 81002 |
|
110 |
104 |
$314.07 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12 |
12 |
$177.12 |
| 99058 |
|
17 |
16 |
$94.95 |
| 81025 |
|
12 |
12 |
$84.09 |
| 90672 |
|
1,121 |
1,121 |
$72.20 |
| 90670 |
|
1,803 |
1,797 |
$42.22 |
| 90651 |
|
122 |
122 |
$19.18 |
| 90698 |
|
870 |
868 |
$16.69 |
| 90715 |
|
37 |
37 |
$0.87 |
| 90734 |
|
191 |
190 |
$0.87 |
| 90744 |
|
137 |
137 |
$0.03 |
| 90707 |
|
248 |
246 |
$0.01 |
| 90660 |
|
48 |
48 |
$0.01 |
| 90680 |
|
247 |
247 |
$0.01 |
| 90716 |
|
270 |
267 |
$0.01 |
| 90677 |
|
36 |
36 |
$0.01 |
| 99072 |
|
34,543 |
32,612 |
$0.00 |
| 90700 |
|
145 |
144 |
$0.00 |
| 91300 |
|
293 |
286 |
$0.00 |
| 90633 |
|
156 |
154 |
$0.00 |
| 90685 |
|
36 |
36 |
$0.00 |
| 96160 |
|
102 |
102 |
$0.00 |
| 90713 |
|
24 |
24 |
$0.00 |
| 99000 |
|
654 |
647 |
$0.00 |
| 91307 |
|
327 |
322 |
$0.00 |
| 3353F |
|
41 |
41 |
$0.00 |
| 90656 |
|
24 |
24 |
$0.00 |
| 90619 |
|
12 |
12 |
$0.00 |